首页 | 本学科首页   官方微博 | 高级检索  
检索        

经动脉介入联合射频消融加体外热疗治疗肝脏恶性肿瘤的临床疗效
引用本文:王薇,徐德立,赵继聪,沈洁,乔炜超,于海生.经动脉介入联合射频消融加体外热疗治疗肝脏恶性肿瘤的临床疗效[J].中国医药指南,2013(34):14-15.
作者姓名:王薇  徐德立  赵继聪  沈洁  乔炜超  于海生
作者单位:河北省承德市肿瘤医院;河北省承德市双滦区人民医院精神科;河北省承德市中心医院胸外科;河北省承德市丰宁县医院
摘    要:目的探讨经动脉介入联合射频消融加体外热疗治疗原发性肝癌及转移性肝癌的临床疗效,进行评价。方法选取医院于2008年10月至2012年12月收治的100例原发性性肝癌、肝转移癌患者,随机分为联合治疗组(50例)和对照组(50例)二组,对照组患者应用肝动脉化疗栓塞术(TACE)进行治疗,联合治疗组为在TACE后1周复查可见有实体肿瘤的患者,对其应用射频消融及体外高频热疗治疗;对比二组患者转移率、生存率、缓解率和生存期,以及患者肿瘤标记物(AFP)情况,运用统计学方法进行评价。结果联合治疗组AFP值下降情况优于对照组,治疗有效率较高,转移率低。结论联合治疗较单纯TACE术能更好地改善患者血清AFP水平;加大肿瘤坏死效果、减小肿瘤体积;降低肿瘤的转移率、复发率,延长患者生存期。

关 键 词:原发性肝癌  转移性肝癌  介入治疗  射频消融  深部热疗

Arterial Interventional Radlofrequency Ablation Plus Hypetthermia in Vitro Clinical Efficacy of the Treatment of Liver Cancer
WANG Wei;XU De-li;ZHAO Ji-cong;SHEN Jie;QIAO Wei-chao;YU Hai-sheng.Arterial Interventional Radlofrequency Ablation Plus Hypetthermia in Vitro Clinical Efficacy of the Treatment of Liver Cancer[J].Guide of China Medicine,2013(34):14-15.
Authors:WANG Wei;XU De-li;ZHAO Ji-cong;SHEN Jie;QIAO Wei-chao;YU Hai-sheng
Institution:WANG Wei;XU De-li;ZHAO Ji-cong;SHEN Jie;QIAO Wei-chao;YU Hai-sheng;Chengde Cancer Hospital;Department of Psychiatric,Shuangluan District People’s Hospital;Department of Thoracic Surgery ,Chengde Central Hospital;Fengning Hospital of Chengde;
Abstract:Objective To discuss the clinical effects of primary liver cancer and metastatic liver cancer combined treatment with through artery interventional radiofrequency ablation, external high frequency heat therapy, and to evaluate. Methods To choose 100 cases of primary liver cancer, metastatic liver cancer patients in the hospital from October in 2008 to December in 2012, and randomly divided into combined treatment group and control group of 50 cases, control group with hepatic artery chemoembolization treatment(TACE), the patients of combined treatment group who can find the solid tumor after a week with TACE to use radiofrequency ablation combined with external high frequency thermotherapy; to contrast transport rate, survival rate, remission rate and lifetime of two groups patients, and the status of AFP, to evaluate with statistical method. Results The decrease of AFP data of combined treatment group is better than control group, and the treatment efficiency is higher, and the transport rate is lower. Conclusion The combined treatment is better than pure TACE in improving the level of patients' AFP; increase the effect of tumor necrosis, decrease the gross tumor volume; reduce the transport rate of tumor, recurrence rate, prolong the patients' lifetime.
Keywords:Primary liver cancer  Metastatic liver cancer  Interventional therapy  RFA  Combined with deep thermal therapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号